title: Effect of probenecid on 5-hydroxyindoleacetic acid in cisternal cerebrospinal fluid of rats with portacaval anastomosis.
abstract: Portal-systemic encephalopathy (PSE) is characterized by a neuropsychiatric disorder progressing through personality changes, to stupor and coma. Previous studies have revealed alterations of serotonin and of its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in brain tissue and CSF in experimental (rat) and human PSE. Increased brain 5-HIAA concentrations could result from its decreased removal rather than to increased serotonin metabolism. In order to evaluate this possibility, CSF 5-HIAA concentrations were measured using an indwelling cisterna magna catheter technique at various times following end-to-side portacaval anastomosis in rats (the most widely used animal model of PSE) treated with probenecid, a competitive inhibitor that blocks the active transport of acid metabolites out of the brain and CSF. Following portacaval anastomosis and probenecid treatment, CSF concentrations of 5-HIAA were increased to a greater extent than in sham-operated controls. When data were expressed as per-cent baseline values, the relative increase of CSF 5-HIAA in portacaval shunted rats following probenecid treatment was not significantly different from sham-operated controls. These findings confirm that increased 5-HIAA in the CNS in experimental PSE results from increased 5HT metabolism or turnover and that the probenecidsensitive acid metabolite carrier is intact in PSE.
authors.affiliation: Neuroscience Research Unit, André-Viallet Clinical Research Centre, Hôpital Saint-Luc, Montréal, Québec, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Bergeron
authors.forename: M S
authors.initials: MS
authors.lastname: Swain
authors.forename: E
authors.initials: E
authors.lastname: Molina-Holgado
authors.forename: T A
authors.initials: TA
authors.lastname: Reader
authors.forename: R F
authors.initials: RF
authors.lastname: Butterworth
mesh_terms: D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002946:Cisterna Magna / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008297:Male; D011167:Portacaval Shunt, Surgical; D011339:Probenecid / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000378:metabolism
chemical_list: D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid